Publication | Closed Access

Streptozotocin-induced diabetes selectively reduces antinociception mediated by μ1-opioid receptors, but not that mediated by μ2-opioid receptors

Pain DisordersHealth SciencesMedicinePain MedicineDiabetesNeuropeptide ReceptorNeuropharmacologyStreptozotocin-induced Diabetesμ2-Opioid ReceptorsPain ManagementPharmacotherapyExperimental PharmacologyPharmacologyμ1-Opioid ReceptorsOpioid Use DisorderPain Research